Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0001415889-25-004727

Chief Executive Officer acquired 96,348 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CAUTREELS WERNER Chief Executive Officer 2025-02-18 Option exercise +96,348 $0.01 $963 104,348 D
Derivatives
CAUTREELS WERNER Chief Executive Officer 2025-02-18 Option exercise · Pre-Funded Warrant (right to buy) −96,348 0 D
Loading xslF345X05/form4-02192025_110231.xml…